This compound is a pharmaceutical intermediate used in the manufacturing of anticoagulant medications. It is presented as a hydrochloride salt with a complex structure containing benzimidazole and pyridine rings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Dabigatran ethyl ester
pharmaceutical intermediate
Dabigatran
pharmaceutical raw material
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
pharmaceutical intermediate
Dabigatran etexilate
pharmaceutical raw material
Asciminib hydrochloride
pharmaceutical raw material
Calcitonin human
pharmaceutical raw material
(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
pharmaceutical raw material
Abiraterone Acetate-d4
pharmaceutical raw material
ethyl 3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;hydrochloride
FHWBKCGBULSVFO-UHFFFAOYSA-N
CCOC(=O)CCN(C1=CC=CC=N1)C(=O)C2=CC3=C(C=C2)N(C(=N3)CNC4=CC=C(C=C4)C(=N)N)C.Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.